Cognism raises £2.8m funding round to expand Enterprise solution

19th December 2018

Cognism, the end-to-end sales acceleration solution providing organisations’ with a more efficient way to prospect, announces that it has raised £2.8m in a funding round from investors including Oliver Wyman and the Newable Ventures Scale up Fund 2.

Cognism raises £2.8m funding round to expand Enterprise solution

Cognism has grown rapidly in revenue in 2018, experiencing 23% monthly growth. The company was seeking expansion capital and selected Oliver Wyman to partner with in order to bring its platform to the Enterprise level. The funding will primarily be used to enhance the solution for Enterprises and also expand the offering into the Financial Services sector.

James Isilay, CEO, Cognism comments: “Cognism is moving beyond sales intelligence and applying its patented machine intelligence technology to understand the revenue challenges at the Enterprise level. With our new investment and collaboration with Oliver Wyman, we will be able to introduce our pioneering Revenue AI technology internationally to the top corporates of the world, driving faster top-line revenue growth.”

James continues, “There is a natural fit between the data and analytics the Cognism platform provides and the strategy that can then be derived to enhance revenue at the Enterprise level. We are keen to showcase this value to this sector and hope our collaboration with Oliver Wyman will propel us forward and continue our strong growth.”

Kai Upadek, Partner at Oliver Wyman comments: “Our clients are continuously looking for new ways to accelerate growth. Cognism technology will provide our clients with dynamic insights into their existing client base, enabling them to develop more targeted solutions and improving sales success. At the same time, Cognism technology will allow our clients to make a step change in their prospecting efforts. Cognism’s data asset will allow our clients to identify prospects matching detailed personas, leveraging data on over 400MM companies and individuals.”

 

Newable Ventures Limited (FRN 795277) is an Appointed Representative of Larpent Newton & Co Ltd. Larpent Newton & Co Ltd is authorised and regulated by the Financial Conduct Authority, FRN 141275.
Neither Newable Capital Limited nor Newable Private Investing Limited are Authorised and Regulated by the Financial Conduct Authority. Risk warning: Your capital is at risk. Investing in early stage companies involves risks including loss of capital, illiquidity, lack of dividends and dilution. Newable Ventures Limited does not give tax or investment advice.
The availability of tax relief depends on individual investors’ circumstances, and on investee companies’ qualifying status, both of which may be subject to change. If you are in doubt about eligibility for tax reliefs or the tax treatment of your investment, you should seek independent tax advice.